XML 57 R46.htm IDEA: XBRL DOCUMENT
v3.21.2

Summary of Warrant Activity (Details) | 9 Months Ended
--- | ---
Sep. 30, 2021 USD ($) $ / shares shares
Common Stock Warrants [Member] |
Accumulated Other Comprehensive Income (Loss) [Line Items] |
Number of Warrants, Beginning Balance |
Weighted Average Exercise Price, Beginning Balance | $ / shares |
Weighted Average Remaining Contractual Term (years), Beginning |
Aggregate Intrinsic Value, Beginning | $ |
Number of Warrants, Assumed from Merger | 5,363,547
Weighted Average Exercise Price, Assumed from Merger | $ / shares | $ 5.19
Weighted Average Remaining Contractual Term (years), Granted | 5 years 7 days
Aggregate Intrinsic Value, Assumed from merger | $ |
Number of Warrants, Granted |
Weighted Average Exercise Price, Granted | $ / shares |
Weighted Average Remaining Contractual Term (years), Granted |
Aggregate Intrinsic Value, Granted | $ |
Number of Warrants, Exercised | (47,298)
Weighted Average Exercise Price, Exercised | $ / shares | $ 4.12
Weighted Average Remaining Contractual Term (years), Exercised | 4 years 7 months 17 days
Aggregate Intrinsic Value, Exercised | $ |
Number of Warrants, Forfeited |
Weighted Average Exercise Price, Forfeited | $ / shares |
Weighted Average Remaining Contractual Term (years), Forfeited |
Aggregate Intrinsic Value, Forfeited | $ |
Number of Warrants, Cancelled/Expired |
Weighted Average Exercise Price, Cancelled/Expired | $ / shares |
Weighted Average Remaining Contractual Term (years), Canceled/Expired |
Aggregate Intrinsic Value, Cancelled/Expired | $ |
Number of Warrants, Ending Balance | 5,316,249
Weighted Average Exercise Price, Ending Balance | $ / shares | $ 5.19
Weighted Average Remaining Contractual Term (years), Ending | 4 years 7 months 2 days
Aggregate Intrinsic Value, Ending | $ | $ 15,905,538
Number of Warrants, Exercisable | 5,316,249
Weighted Average Exercise Price, Exercisable | $ / shares | $ 5.19
Weighted Average Remaining Contractual Term (years), Exercisable | 4 years 7 months 2 days
Aggregate Intrinsic Value, Exercisable | $ | $ 15,905,538
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised | 47,298
Pre-funded Common Stock Warrants [Member] |
Accumulated Other Comprehensive Income (Loss) [Line Items] |
Number of Warrants, Beginning Balance |
Weighted Average Exercise Price, Beginning Balance | $ / shares |
Weighted Average Remaining Contractual Term (years), Beginning |
Aggregate Intrinsic Value, Beginning | $ |
Number of Warrants, Assumed from Merger | 986,486
Weighted Average Exercise Price, Assumed from Merger | $ / shares | $ 0.002
Weighted Average Remaining Contractual Term (years), Granted |
Aggregate Intrinsic Value, Assumed from merger | $ |
Number of Warrants, Granted |
Weighted Average Exercise Price, Granted | $ / shares |
Weighted Average Remaining Contractual Term (years), Granted |
Aggregate Intrinsic Value, Granted | $ |
Number of Warrants, Exercised | (466,216)
Weighted Average Exercise Price, Exercised | $ / shares | $ 0.002
Weighted Average Remaining Contractual Term (years), Exercised | 0 years
Aggregate Intrinsic Value, Exercised | $ |
Number of Warrants, Forfeited |
Weighted Average Exercise Price, Forfeited | $ / shares |
Aggregate Intrinsic Value, Forfeited | $ |
Number of Warrants, Cancelled/Expired |
Weighted Average Exercise Price, Cancelled/Expired | $ / shares |
Aggregate Intrinsic Value, Cancelled/Expired | $ |
Number of Warrants, Ending Balance | 520,270
Weighted Average Exercise Price, Ending Balance | $ / shares | $ 0.002
Weighted Average Remaining Contractual Term (years), Ending |
Aggregate Intrinsic Value, Ending | $ | $ 3,744,903
Number of Warrants, Exercisable | 520,270
Weighted Average Exercise Price, Exercisable | $ / shares | $ 0.002
Weighted Average Remaining Contractual Term (years), Exercisable |
Aggregate Intrinsic Value, Exercisable | $ | $ 3,744,903
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised | 466,216
Series C Convertible Preferred Stock [Member] |
Accumulated Other Comprehensive Income (Loss) [Line Items] |
Number of Warrants, Beginning Balance |
Weighted Average Exercise Price, Beginning Balance | $ / shares |
Weighted Average Remaining Contractual Term (years), Beginning | 0 years
Aggregate Intrinsic Value, Beginning | $ |
Number of Warrants, Assumed from Merger | 27,500
Weighted Average Exercise Price, Assumed from Merger | $ / shares | $ 8.00
Weighted Average Remaining Contractual Term (years), Granted | 3 years 7 months 24 days
Aggregate Intrinsic Value, Assumed from merger | $ |
Number of Warrants, Granted |
Weighted Average Exercise Price, Granted | $ / shares |
Weighted Average Remaining Contractual Term (years), Granted | 0 years
Aggregate Intrinsic Value, Granted | $ |
Number of Warrants, Exercised |
Weighted Average Exercise Price, Exercised | $ / shares |
Weighted Average Remaining Contractual Term (years), Exercised | 0 years
Aggregate Intrinsic Value, Exercised | $ |
Number of Warrants, Forfeited |
Weighted Average Exercise Price, Forfeited | $ / shares |
Weighted Average Remaining Contractual Term (years), Forfeited | 0 years
Aggregate Intrinsic Value, Forfeited | $ |
Number of Warrants, Cancelled/Expired |
Weighted Average Exercise Price, Cancelled/Expired | $ / shares |
Weighted Average Remaining Contractual Term (years), Canceled/Expired | 0 years
Aggregate Intrinsic Value, Cancelled/Expired | $ |
Number of Warrants, Ending Balance | 27,500
Weighted Average Exercise Price, Ending Balance | $ / shares | $ 8.00
Weighted Average Remaining Contractual Term (years), Ending | 3 years 2 months 8 days
Aggregate Intrinsic Value, Ending | $ |
Number of Warrants, Exercisable | 27,500
Weighted Average Exercise Price, Exercisable | $ / shares | $ 8.00
Weighted Average Remaining Contractual Term (years), Exercisable | 3 years 2 months 8 days
Aggregate Intrinsic Value, Exercisable | $ |
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised |

X
- Definition Net number of non-option equity instruments assumed from merger. + References No definition available. + Details
Name: | MYMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedFromMerger
Namespace Prefix: | MYMD_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Share based compensation arrangement by share based payment award non option equity instruments assumed from merger in period weighted average exercise price. + References No definition available. + Details
Name: | MYMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedFromMergerInPeriodWeightedAverageExercisePrice
Namespace Prefix: | MYMD_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of shares into which fully or partially vestednon-option equity outstanding as of the balance sheet date can be currently converted under the non-option equity plan. + References No definition available. + Details
Name: | MYMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
Namespace Prefix: | MYMD_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of non-option equity outstanding and currently exercisable under the non-option equity plan. + References No definition available. + Details
Name: | MYMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice
Namespace Prefix: | MYMD_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Share based compensation arrangement by share based payment award non option equity instruments exercises in period weighted average exercise price. + References No definition available. + Details
Name: | MYMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
Namespace Prefix: | MYMD_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Share based compensation arrangement by share based payment award non option equity instruments expired in period weighted average exercise price. + References No definition available. + Details
Name: | MYMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice
Namespace Prefix: | MYMD_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Share based compensation arrangement by share based payment award non option equity instruments forfeited in period weighted average exercise price. + References No definition available. + Details
Name: | MYMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice
Namespace Prefix: | MYMD_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of non-option equity. + References No definition available. + Details
Name: | MYMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice
Namespace Prefix: | MYMD_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average remaining contractual term for vested portions of non-option equity outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | MYMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingExercisableWeightedAverageRemainingContractualTerm1
Namespace Prefix: | MYMD_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan. + References No definition available. + Details
Name: | MYMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
Namespace Prefix: | MYMD_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Weighted average remaining contractual term for non-option equity awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | MYMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning
Namespace Prefix: | MYMD_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average remaining contractual term for non-option equity awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | MYMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding
Namespace Prefix: | MYMD_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | MYMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsAssumedFromMergerIntrinsicValue
Namespace Prefix: | MYMD_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | MYMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsCancelledOrExpiredIntrinsicValue
Namespace Prefix: | MYMD_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Aggregate Intrinsic Value, Exercised. + References No definition available. + Details
Name: | MYMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedIntrinsicValue
Namespace Prefix: | MYMD_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Aggregate Intrinsic Value, Forfeited. + References No definition available. + Details
Name: | MYMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeitedIntrinsicValue
Namespace Prefix: | MYMD_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Aggregate Intrinsic Value, Granted. + References No definition available. + Details
Name: | MYMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantedIntrinsicValue
Namespace Prefix: | MYMD_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Sharebased compensation arrangement by sharebased payment award non options outstanding intrinsic value. + References No definition available. + Details
Name: | MYMD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue
Namespace Prefix: | MYMD_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Sharebased compensation arrangement by sharebased payment award non options exercisable intrinsic value. + References No definition available. + Details
Name: | MYMD_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableIntrinsicValue1
Namespace Prefix: | MYMD_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Weighted average remaining contractual term for non-option equity awards assumed from merger, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | MYMD_WeightedAverageRemainingContractualTermYearsAssumedFromMerger
Namespace Prefix: | MYMD_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average remaining contractual term for non-option equity awards exercised, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | MYMD_WeightedAverageRemainingContractualTermYearsExercised
Namespace Prefix: | MYMD_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average remaining contractual term for non-option equity awards expired, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | MYMD_WeightedAverageRemainingContractualTermYearsExpired
Namespace Prefix: | MYMD_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average remaining contractual term for non-option equity awards forfeited, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | MYMD_WeightedAverageRemainingContractualTermYearsForfeited
Namespace Prefix: | MYMD_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Weighted average remaining contractual term for non-option equity awards granted, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | MYMD_WeightedAverageRemainingContractualTermYearsGranted
Namespace Prefix: | MYMD_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of non-option equity instruments exercised by participants. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(4) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(3) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Net number of non-option equity instruments granted to participants. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(ii) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=MYMD_CommonStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=MYMD_PreFundedCommonStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=MYMD_SeriesCConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |